INTRODUCTION
Contrast agents have been regularly used to improve the contrast between and within soft tissues and overcome the limits of the available contrast originating from differences in relaxation times (T 1 /T 2 ), spin mobility (diffusion, perfusion), and spin density. By affecting the longitudinal and the transverse relaxation rate of surrounding water protons, paramagnetic and superparamagnetic contrast agents enhance the contrast to noise ratio (CNR) by either increasing or reducing the signal in targeted regions.
Manganese (Mn 2þ ) has proven to be a very interesting MR contrast agent. Being an analog to Ca2 þ and paramagnetic (due to the five unpaired electrons on the 3d electronic orbital), Mn 2þ can enter voltage gated calcium channels and enhance the signal in T 1 -weighted images in regions of Mn 2þ accumulation due to local T 1 shortening. Studies using Mn 2þ as a contrast agent have been limited to animal models because of its high cellular toxicity, causing heart and hepatic failure (1, 2) , and, in the case of chronic Mn 2þ exposure, leading to a form of Parkinsonism (3) . In rodents, various in vivo brain studies have been performed to map neuronal connections (4), functional activity (5) , and enhance the brain cytoarchitecture (6,7), demonstrating to be an useful MRI marker of neuronal activity and calcium influx in tissues. As Mn 2þ is not able to cross the blood brain barrier (BBB) three main approaches have been used to deliver Mn 2þ to the targeted brain regions: infusion of Mn 2þ followed by BBB disruption (8) ; local injection (4); systemic administration, with the enhancement being first observed in choroid plexus, cerebrospinal fluid, and only latter in tissues (9) . The least invasive method, systemic administration, has enabled to depict several structures rich or with active voltage gated calcium channels such as layers in the hippocampus, cortex, and olfactory bulb (6, 7, 10) .
Over the recent years, phase imaging has gained a significant interest (11, 12) thanks to the increase of the magnetic fields available on clinical MR scanners. At fields above 3 Tesla, it was shown that the contrast to noise ratio (CNR) observed in phase images between gray and white matter was superior to that of conventional magnitude images, yielding additional anatomical information in the brain including the observation of subcortical contrast (11, 12) . In rodent studies, phase imaging at high magnetic field with an in-plane resolution of 33 mm was found to give anatomical details with clear depiction of cytoarchictectural features such as hippocampal fields, cortical and cerebellar layers, structures typically not easily discernible in T 1 , T 2 , or T 2 * magnitude images (13) .
The observed contrast in phase imaging is due to magnetic susceptibility induced frequency shifts which increase linearly with the magnetic field strength. Even though its origin is still not clear, many mechanisms have been proposed (11, 14, 15) with tissue bulk magnetic susceptibility playing a major role in modulating the phase shifts observed across the brain. The origin of such bulk susceptibility has been found to have different origins in different brain regions. In humans, the contrast observed in deep gray matter nuclei and in intracortical contrast has been attributed to local iron concentration (16, 17) , while in rodents, the susceptibility difference responsible for gray and white matter contrast has been demonstrated to have myelin origin (18) (19) (20) .
To the best of our knowledge, manganese enhanced MRI (MEMRI) has only been assessed using T 1 contrast. The increasingly strong magnetic fields available potentiate stronger Mn 2þ magnetic susceptibility effects, making phase imaging a natural candidate to profit from Mn 2þ uptake in tissues. Mn 2þ should induce a phase shift observable with phase imaging and, combined with its high sensitivity to endogenous magnetic susceptibility distribution and high CNR, could be exploited to further enhance neural architecture in animal models.
The present work was designed to investigate the above hypothesis by assessing Mn 2þ potential input on phase imaging at 14.1T and to determine the level of phase contrast enhancement obtained following systemic administration in comparison to the standard imaging protocol used in MEMRI, namely T 1 -weighted imaging. The phase shift and the contrast enhancement as a function of the Mn 2þ dose were also investigated to assess its linearity and sensitivity in comparison to T 1 -weighted imaging. Finally, the potential of quantification of Mn 2þ uptake based on phase imaging is addressed.
METHODS

Animal Preparation
Experiments were carried out in 12 male SpragueDawley rats (weighting 200-300 g). All animal experiments were conducted according to federal and local ethical guidelines and the protocols were approved by the local regulatory body.
The Mn 2þ administration protocol consisted of a tail vein infusion at a rate of 1.0 mL/h of an isotonic MnCl 2 (Sigma-Aldrich, St Louis, MO) solution prepared with a concentration of 120 mM. During MnCl 2 infusion, all rats were anesthetized under 2% isoflurane and their body temperature was maintained at 38 6 0. 5 C by means of a heating pad. Four different doses of MnCl 2 were used: 25 (4 animals), 75 (4 animals), 125 (4 animals), and 175 mg/kg. The dose of 175 mg/kg was discarded due to a high mortality rate observed (90%). After infusion, rats were returned to their cages with free access to food and water and held under a 12 h/12 h light/dark regimen.
MRI was performed prior and 24h post MnCl 2 infusion. During the MR image acquisition, the rats were kept under anesthesia (1.5-2% isoflurane delivered through a face mask) and were fixed using a custom made stereotaxic holder. Respiration rate was monitored using a pressure pillow placed under the rat's abdomen (respiration rate of 60 6 3 breaths per minute). Body temperature was monitored using a rectal temperature probe and maintained at 38 6 0.5 C by a heated water bath.
Phantom Study: MnCl 2 Relaxometry at 14.1T
A phantom containing seven cylindrical tubes with different Mn 2þ concentration (from 0 mM to 200 mM dissolved in distilled water) was produced. From the T 1 (1/ R 1 ) and frequency shift maps measured across the Mn 2þ concentrations, it was possible to compute the relaxivity parameters r 1 and magnetic susceptibility x([Mn 2þ ]). (Details of the imaging and processing protocols will be given in the MRI and Phantom Data sections respectively).
MRI
All scans were performed on a 14.1T/26 cm horizontal bore magnet (Varian/Magnex Scientific). The MnCl 2 relaxometry protocol (performed on the phantom described on the previous paragraph) was acquired using a high pass birdcage coil with an inner diameter of 46 mm and length of 30 mm. In vivo rat brain images were acquired using a home built quadrature surface coil as radiofrequency (RF) transceiver with two geometrically decoupled 21 mm loops resonating at 600 MHz. To take full advantage of the high signal to noise ratio (SNR), the surface coil was carefully and systematically positioned over the brain regions under investigation, regions known to be rich/or with active voltage gated calcium channels that are susceptible to Mn 2þ uptake (6,7): olfactory bulb (OB) including the olfactory nerve layer (ONL), glomerular layer (GL) and mitral cell layer (ML); the hippocampus (HC) including the CA formation of the hippocampus and the dentate gyrus. To take advantage of using thick slices (compared with the in-plane resolution) and to further improve the SNR without significantly increasing partial volume effects, both the slices covering the hippocampus and the olfactory bulb were positioned coronally.
Magnetic field homogeneity was adjusted using FAST-MAP (21) in a large volume located in the different regions. Water spectra linewidth of 21-26 Hz were obtained over a typical voxel size of 7 Â 10 Â 6 mm 3 in cortex/hippocampus regions and 2 Â 2 Â 4 mm 3 in the OB. The complete acquisition protocol described in the following paragraph was applied before and 24h post Mn 2þ systemic administration.
T 1 Mapping
T 1 mapping was performed using a multi-slice multishot inversion-recovery Look-Locker Segmented Echo Planar Imaging sequence (22, 23) . A slice-selective 180 adiabatic pulse (hyperbolic secant, hs8) was used to invert the magnetization followed by low flip angle slice-selective pulses (FA ¼ 20 ) that sampled the inversion recovery curve in 20 points with inversion times from 50 ms to 4050 ms (with an inter-excitation delay of 200 ms). The repetition time (TR) was set to 24.5 s, sufficient for the full recovery of the longitudinal magnetization allowing 6 slices to be acquired per TR while the interexcitation delay was chosen to guarantee the accuracy of T 1 values down to 400 ms (22, 23 (24) .
T 1 -Weighted and Phase Images T 1 -weighted and phase images were acquired using a gradient echo multi-slice sequence (GEMS) with respiration gating to reduce respiration induced artifacts which suggested that all images were acquired with a TR$1s. The small and slow variations in respiration rate could only generate a maximum signal variation (due to TR fluctuations) of 64%, which was considered too small to require any extra corrections.
For phase images, the flip angle was optimized to maximize the signal intensity in the specific regions of interest. The echo time (16 ms) was chosen to approximately match the gray matter T 2 * and, hence, optimize phase contrast (13) . The acquisition bandwidth was chosen to maximize signal without introducing effective resolution reduction due to T 2 * decay during the readout (tacq ¼ 15.9 ms).
For T 1 -weighted images, echo time was reduced (5 ms) and acquisition bandwidth was increased to emphasize the T 1 contrast while maintaining sufficient SNR. The flip angle was chosen to be close to 90 to enhance the T 1 contrast in the regions where contrast enhancement was expected, while avoiding undesirable inversions in the regions closest to the coil. 
Frequency Shift Maps
To establish the magnetic susceptibility of Mn 2þ in the phantom, frequency shift maps were acquired using a multi-gradient echo sequence. Fifteen gradient echo images (4.5 to 60.5 ms) were obtained with the following parameters: TR ¼ 900 ms, FA ¼ 40 , FOV ¼ 30*30 mm 2 , resolution ¼ 234*234*800 mm 3 .
Data Processing
T 1 maps were calculated pixel by pixed using a NelderMead fitting algorithm (25) . Due to the coil setup (surface coil) a three-parameter fit (T 1 , M 0 and flip angle a) was done to take into account the transmit field inhomogeneity. Steady state signal was considered in the algorithm to remove any bias from possible magnetization not fully recovered at the end of the TR. Frequency maps were established from a linear fit to the phase change over the 15 echoes. Phase images were unwrapped (26) and the background field contributions originating from imperfect shimming, air tissue interfaces were filtered using the SHARP algorithm (17) . This methodology does not remove entirely phase variations related to the transmitting and receiving B 1 field which can be removed by applying a high pass filter with a wide Gaussian width.
Phantom Data
Regions of interest (ROIs) were placed within each MnCl 2 tube. The relaxation rate R 1 and frequency values were measured from the respective T 1 and frequency maps for each ROI . The different values were then plotted as a function of [Mn 2þ ] and a linear regression was performed to find the longitudinal relaxivity,
For the frequency map, the outside compartment ([Mn 2þ ]¼0) was used as a reference. A frequency shift per millimolar, df pmM , was calculated
Subsequently, the magnetic susceptibility per millimolar was calculated using the following expression df pmM ¼ À1/3*gB 0 x pmM (27) , where g is the gyromagnetic constant ratio, which represents the relationship between the frequency shift difference and the susceptibility difference for an infinite cylinder aligned along the main magnetic field.
In Vivo Data
The changes in T 1 due to Mn 2þ as a function of the different doses were calculated by selecting ROIs in the cortex, hippocampus, corpus callosum (within the same slice) and in different fields of the OB (Fig. 4) . Although manganese can be transported by means of the axons (28), its enrichment in white matter is limited as it mainly accumulates in synaptic regions of gray matter (29) . To measure the contrast enhancement throughout the Mn 2þ doses, the CNR was calculated as the signal difference between the tissue of interest and a region devoid of Mn 2þ enhancement (WM) divided by the standard deviation of the noise (s). The T 1 -weighted contrast of the cortex and dentate gyrus of the hippocampus were established in respect to the corpus callosum whereas the contrast of the OB was established by subtracting the signal from the anterior commissure, intrabulbar part (aci) (Fig. 4) .
Likewise, phase enrichment (Df GM-WM ) and phase CNR were established considering ROI's in the same slice and the latter was calculated using the following equation:
With Signal av =(Signal GM þ Signal WM )/2, TE the echo time used, f GM and f WM the frequency shift of gray matter and white matter, respectively, and s the standard deviation of the background noise measured outside the brain within artifact free regions (11) .
RESULTS
Relaxivity r 1 and df pmM of Mn 2þ at 14.1T
To determine the relaxivity parameters of Mn 2þ at 14.1T, the relaxation rates, R 1 , and frequency shifts, Df, were measured using a phantom containing seven cylindrical tubes with Mn 2þ concentrations ranging from 0 to 200 mM, (Fig. 1) . Both quantities showed the expected linear relationship with Mn 2þ concentration (R 2 > 0.98). The measured longitudinal relaxivity, r 1 , was established at 5.5 6 0.1 s
À1
.mM À1 (Fig. 1a) . The frequency shift as a function of Mn 2þ df pmM was measured at 251 6 12 Hz.mM À1 (Fig.  1b) resulting in a susceptibility of Mn 2þ of À1.25 6 0.06 ppm.mM
.The apparent transverse relaxivity r 2 * was also established at 234 6 8 s
.mM À1 (data not shown).
Induced Phase and T 1 Changes 24h Post Systemic Mn 2þ
Administration
T 1 -weighted imaging
To qualitatively determine the effect of systemic Mn 2þ administration on T 1 contrast, T 1 -weighted images of the olfactory bulb, cortex, and hippocampus acquired before and 24h after a 125 mg/kg systemic Mn 2þ administration were compared (Fig. 2) .
Before Mn 2þ administration, tissue structures in the OB, cortex, and hippocampus regions were poorly discernible despite the high in-plane resolution of 58mm (Fig. 2) .
Twenty-four hours after Mn 2þ systemic administration, an overall increase in SNR was observed in all regions (OB: þ31%; cortex þ38%; hippocampus: þ66%) followed by a significant increase in tissue contrast in manganeseenhanced structures. In the OB, several anatomic features were enhanced and well depicted such as the external plexiform (EPL), internal plexiform (IPL), the mitral cell layer (ML), granular cell layer (GrL), and olfactory nerve layer (ONL. Subregional anatomic structures of the hippocampus were also well visualized with clear depiction of CA1, CA2, CA3, DG of the hippocampus (black arrows Fig. 2 ).
Phase imaging
To qualitatively determine the effect of Mn 2þ on phase contrast, phase images acquired before and 24h after a 125 mg/kg Mn 2þ administration, in the same slices/ regions of interest as the T 1 -weighted images, were compared (Fig. 3) .
Before Mn 2þ administration, the high contrast to noise ratio (CNR) given by the phase image already enabled to depict several structures of the olfactory bulb such as the external plexiform (EPL) and internal plexiform (IPL), granular cell layer (GrL), and olfactory nerve layer (ONL) (Fig. 3) . Twenty-four hours following Mn 2þ administration, Mn 2þ accumulation resulted in an increase of CNR in all structures rich or with active voltage gated calcium channels, further enhancing the cytoarchitectural features (black arrows Fig. 3 ) which were already depicted beforehand with a clear emphasis of the mitral cell layer (ML) and the glomerular layer (GL).
Likewise, in the cortex-hippocampus region and before Mn 2þ administration, phase imaging yielded substantial anatomical contrast allowing the identification of hippocampus structures, gray matter cortical layer (Fig. 3) and white matter structures such as the corpus callosum, the internal capsule, and the fornix (as expected from previous studies). A phase shift and CNR increase mainly in the dentate gyrus, CA of the hippocampus and cortical layer (black arrows Fig. 3 To define the effect of the dose of Mn 2þ administration on both T 1 and phase images, the Mn 2þ dose was varied from 0, 25, 75, and 125 mg/kg. Figure 4 shows the corresponding T 1 map, phase and T 1 -weighted images acquired in the cortex-hippocampus and olfactory bulb regions with Mn 2þ doses ranging from 0 to 125 mg/kg. At the lowest dose for both phase and T 1 -weighted images, enhancement of the CA1, CA2, CA3, and DG of the hippocampus (Fig. 4a) and external, internal plexiform, mitral cell, olfactory nerve, and granular cell layers (Fig. 4b) were already visible. In comparison to the cortexhippocampus region, the contrast enhancement in the olfactory bulb was more pronounced for both imaging methods. Such enhancement progressed with the increasing doses of Mn 2þ , offering a better delineation of the cytoarchitectural features cited above in both imaging methods. These observations were supported by the observed T 1 decrease in the corresponding T 1 maps. Quantification of the R 1 increase is shown in Figure 5a as the evolution of the relaxation rate DR 1 Figure 5b shows the evolution of the frequency shift difference Df as a function of Mn 2þ dose measured in the same ROIs as in Figure 5a . Df was calculated in the same manner as DR 1 . However, as the frequency is not absolute (due to background field removal), Df was established by subtracting respectively the frequency value of the white matter in both Mn 2þ and preinfusion control data (corpus callosum for the cortex and dentate gyrus; anterior commissure intrabulbar part for the olfactory bulb-yellow regions in Figs. 3 and 4) . Again, a monotonic increase of the frequency difference as a function of Mn 2þ uptake is observed. The smallest increase of Df was again observed in the cortex. However, in opposition to DR 1 , the olfactory bulb showed the greatest Df increase.
T 1 -Weighted and Phase CNR Comparison
To compare the sensitivity of phase imaging and T 1 -weighted images at 14.1T, the dose dependence of the CNR was compared for both imaging methods and in the same regions of interest as described in the "Data Processing" paragraph. CNR for both imaging methods was established by subtracting the signal of neighboring white matter for each region and for each given Mn 2þ dose. Figure 6 and Table 1 show that with increasing Mn 2þ dose, both phase and T 1 -weighted CNR increased progressively in all regions of interest. Globally, phase contrast outperformed our T 1 -weighted imaging protocol showing always greater contrast. Also the CNR increase was greater in 7 of the 9 regions studied for the phase contrast when compared with the T 1 -weighted contrast. In terms of relative increase of the CNR (relative to the initial contrast, see values inside the brackets on Table  1 ) between the control region and the regions with active Mn 2þ uptake, T 1 -weighted images showed superior fractional CNR increase in 6 of the 9 regions studied.
DISCUSSION
The study reports for the first time the longitudinal relaxivity parameters (r 1 ) and the magnetic susceptibility x pmM of Mn 2þ at 14.1T. Magnetic susceptibility values demonstrate that Mn 2þ enhancement could be explored in phase imaging (Fig. 1) . Figs. 3 and  2, respectively) . The results from the T 1 -weighted images are consistent with previous MEMRI studies (6, 7, 10) . Mn 2þ enhancement was manifested in T 1 -weighted imaging by a signal increase due to the reduction in T 1 . In phase imaging, Mn 2þ uptake not only resulted in increased frequency shift differences (penultimate term of Eq. [3] ) but also in increased SNR due to the reduction in T 1 (first term of Eq. [3] ). Mn 2þ uptake also introduces a signal attenuation due to T 2 * decay which could hamper, at high magnetic field, the assessment of MEMRI contrast by phase imaging for high Mn 2þ concentrations and long echo times. However, for the typically Mn 2þ concentrations found in vivo, it should be noted that this is not a concern as the phase CNR continues to increase (see Appendix 1) . The gain in phase contrast associated with T 1 reduction and increased frequency shift make phase imaging, and potentially susceptibility mapping, a promising tool in the field of MEMRI. (0)). Df in the dentate gyrus and cortex was measured by subtracting the WM frequency of the corpus callosum in both Mn 2þ and preinfusion control data. Df of the olfactory bulb was measured by subtracting the WM frequency of the anterior commissure, intrabulbar part. From 0 mg/kg to 125 mg/kg, the dentate gyrus showed the highest increase indicating a higher Mn 2þ uptake followed by the olfactory bulb and cortex. Likewise, a monotonic increase of the frequency difference as a function of Mn 2þ uptake was observed in all regions. The smallest increase of Df was again observed in the cortex. However, in opposition to DR 1 , the olfactory bulb showed the highest Df increase. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] FIG. 6. Plots of the contrast to noise ratio of T 1 -weighted (a) and phase imaging (b) as a function of the manganese dose for different brain regions (cortex, dentate gyrus, and olfactory bulb). At control level and for all regions, phase CNR was significantly higher than T 1 -weighted CNR. From 0 to 125 mg/kg, both phase and T 1 -weighted CNR increased progressively in all regions of interest. The cortex exhibited the slowest CNR increase in both imaging methods while the dentate gyrus and olfactory bulb showed the highest. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Before Mn 2þ infusion, phase imaging, thanks to its high CNR between and within gray and white matter, allowed the depiction of structures which are only discernible after Mn 2þ infusion in T 1 -weighted imaging (see Figs. 2 and 3) . Furthermore, other tissue structures such as white matter fiber tracts (fornix and mamillothalamic tract) not detectable on T 1 -weighted images both before and after Mn 2þ enhancement were clearly discernible in phase images. Overall, by further increasing phase CNR which was, before Mn 2þ infusion, higher than in the T 1 -weighted imaging, Mn 2þ infusion enabled to further explore the brain structure and give additional information in comparison to the used T 1 -weighted imaging protocol. As such, Mn 2þ can be considered as a MR phase contrast agent used to enhance neuro-architectonic contrast.
Twenty-four hours following Mn 2þ administration, veinous structures were more pronounced, indicating an increase of susceptibility present in the veins that could be either due to an increase in the deoxyhemoglobin or manganese concentration. Independently of the origin of such vessel susceptibility changes, it has been shown that point-like susceptibility inclusions inside the vasculature contribute only to a very small extent to the phase contrast between gray and white matter (13, 31) . Its contribution can be ruled out making the observed increase of contrast in tissue to be associated to the Mn 2þ uptake in those regions.
The sensitivity of phase-based Mn 2þ enhancement at 14.1T was also studied at different Mn 2þ doses and compared with T 1 -weighted imaging in different brain ROIs. Qualitatively in Figures 3 and 4 , contrast in regions rich or with active voltage gated calcium channels such as the dentate gyrus, cortex, and olfactory bulb continued to increase with the increasing Mn 2þ doses for both imaging methods offering a better delineation of the cytoarchitectural features. Quantification of R 1 changes from the T 1 maps, in the selected brain regions cited above, indicated a heterogeneous R 1 increase/Mn 2þ uptake throughout the Mn 2þ doses with the cortex exhibiting the smallest increase and the olfactory bulb and dentate gyrus the strongest increase ( Fig. 5a and Table  1 ). These results are in agreement with a previous study made by Lee et al (9) . The very low, but constant, R 1 increase observed in the corpus callosum (þ0.02s À1 6 0.03 from 0 to 125 mg/kg) is a confirmation of the very weak presence of voltage gated calcium channels in white matter (32) . Mn 2þ distribution by means of the cerebrospinal fluid and paravascular spaces following systemic administration are the main pathways of Mn 2þ enhancement in the rat brain (9) . Nonspecific diffusion of Mn 2þ ions might have an influence on the minimal R 1 increase seen in the corpus throughout the Mn 2þ doses. Alternatively, it could also be a consequence of the relatively low resolution of the T 1 maps and the point spread function due to the EPI readout, making the increase in R 1 observed in the WM simply a partial volume effect. Nevertheless, the corpus callosum R 1 increase was very weak (when compared with the remaining regions) and could be considered non significant for the CNR study. From 0 to 125 mg/kg, both Df and DR 1 increased monotonically in all regions despite correlation between DR 1 and Df being different in the selected brain regions (8.8 in cortex, 5.4 in the DG and 13.1 in the OB). Nonetheless, the increase in contrast observed in the DR 1 and Df (see Fig. 5 ), when taking into account the phantom study results (Fig. 1) administration indicated that, overall, from 0 to 125 mg/ kg, Mn 2þ enhancement was more pronounced in phase imaging than in T 1 -weighted imaging protocol used although its fractional increase was greater for the latter (see Table 1 ). This observation is highly dependent on the sequence and parameters used to obtain the T 1 -weighted images. In this study, a gradient echo with a fixed TR of 1 second was applied to avoid respiration induced artifacts, under such constraints the optimal flip angle to obtain T 1 contrast is $90
. Had our setup allowed for a three-dimensional acquisition, a TR as short as 10 ms could have been used together with an excitation of 11 which would have increased our contrast per unit of time to the DR 1 by $10%. Other studies in literature have used spin echo sequences (9, 10) or inversion recovery sequences (4) . The use of a gradient echo with a short echo time was preferred to a spin echo sequence due to the B 1 inhomogeneity associated with the use of a surface coil. The signal from a spin echo sequence has a sin 3 (90*B 1 ) dependence on B 1 (33) , significantly limiting the range over which acceptable SNR In between brackets, the percentage increase of contrast in respect to the contrast observed in absence of Mn 2þ administration is shown.
and T 1 -weighting would be achieved on our setup and which can only be overcome by the usage of adiabatic refocusing pulses (34) . A gradient echo sequence introduces a Mn 2þ related signal attenuation due to T 2 * decay. The reduction in contrast due to the use of a gradient echo sequence (given an apparent transverse relaxivity of Mn 2þ ) is bound to be smaller than 50% for the largest Mn 2þ dose, not enough to justify the 4-7 times reduction in T 1 -weighted contrast in respect to phase found in Table 1 . Although it has been demonstrated inversion recovery-based sequences (such as the MPRAGE) offer superior T 1 -contrast with reduced sensitivity to B 1 homogeneity thanks to the use of adiabatic inversion pulses and efficient low flip angle excitations for the readout, analytical analysis of the contrast efficiency (35) of the spoiled gradient echo used in this study versus an MPRAGE sequence with the same echo time, constraint of 128 phase encoding steps per excitation (TR ¼ 2-4 s, flip angle ¼ 8 TI ¼ 1.5 s) showed that the MPRAGE would not necessarily provide an improved T 1 -weighted contrast in comparison to our protocol when considering the typical relaxation parameters measured in the dentate gyrus (R 1 of 0.46 s À1 and a DR 1 of 0.35s À1 following Mn 2þ systemic administration at maximum dose of 125 mg/kg). It is important to point out that, as the magnetic susceptibility induced frequency shift is linearly dependent to the static magnetic field, at lower magnetic fields (such as the typically available for animal scanning 4.7-7T), the CNR of the phase contrast will be lower and it remains to be determined at which field strength an optimized T 1 -weighted imaging protocol is likely to outperform phase imaging.
One of the pitfalls of in vivo phase imaging is its sensitivity to physiology and respiration induced artifacts due to the long echo time used. In our study, such artifacts were minimized by using respiration triggering. Another important limitation of phase imaging is the difficulty of obtaining reliable values in regions close to air/tissues interfaces such as the olfactory bulb. Despite the care taken when performing background filtering, the phase image in the olfactory bulb is pronouncedly affected by phase variations arising from air/tissue interfaces making structures situated at the extremities (such as the olfactory glomeruli, the glomerular layer) difficult to discern.
Phase-based MEMRI can, potentially, offer a higher resolution and contrast than that obtainable with T 1 -weighted imaging and be equally quantitative. To make phase-based Mn 2þ quantification, it would be important to perform a quantitative susceptibility mapping (36, 37) . The lack of this step on our analysis is likely to explain the difference in ordering observed between the frequency shift enhancement in the olfactory bulb, hippocampus, and in R 1 maps. The measured frequency shift reflects not only the local increase of the Mn 2þ uptake, but also its geometrical shape in respect to the static magnetic field. To be able to compute susceptibility maps, it would be beneficial to obtain a closer to isotropic resolution and bigger coverage than what was achievable with a surface coil. Two of the main difficulties when evaluating susceptibility maps is the fact that the forward model (role of macromolecular contribution (15), anisotropic susceptibility (38) , and microstructure (14)) is not fully understood and that the susceptibility values should be always seen as relative measure. In the case of studying Mn 2þ uptake, Mn 2þ can be considered as simple isotropic susceptibility contrast agent while any other bias of the QSM method will be the same prior and post to Mn 2þ infusion. Also, from the results observed in this study using R 1 mapping (see Fig. 5a ), white matter structures would form an ideal reference throughout the enrichment. Such an approach would offer fully quantitative Mn 2þ uptake maps.
CONCLUSIONS
We conclude from the present study that MEMRI can be assessed by phase imaging at high magnetic field. Although Mn 2þ had a stronger effect on T 1 -weighted imaging, phase imaging demonstrated to have superior CNR following Mn 2þ systemic administration. Future work will be directed toward exploring high resolution and high contrast manganese enhanced phase images to obtain quantitative manganese uptake information by using quantitative susceptibility mapping.
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APPENDIX 1
For a given echo time and as [Mn 2þ ] increases, the increased magnetic susceptibility induces an increase in phase but also a reduction in gradient echo (GRE) signal intensity due to T 2 * attenuation. As phase CNR is correlated to both magnitude SNR and phase difference for a given echo time, MEMRI assessment by phase imaging at ultra-high field could be hampered by high [Mn 2þ ] if the reduction in T 2 * is large, relative to the echo time used. To address this point, simulations were performed using a range of Mn 2þ concentrations going beyond those found in the in vivo rodent brain following Mn 2þ systemic administration (30) . The GRE signal was simulated using the relaxation parameters experimentally found for the Dentate Gyrus (R 1control , DR 1 at maximum dose of 125 mg/kg) and Mn 2þ relaxivities (reported in Section Relaxivity r 1 and df pmM of Mn 21 at 14.1T). The GRE magnitude CNR was defined as the signal difference prior and post Mn 2þ infusion (125 mg/kg). Phase CNR was defined similarly and as described in Eq. [3] . Figure A1 (a, b) shows the expected magnitude CNR for a 90 degree and Ernst angle setting respectively. As expected, in both cases the maximum GRE CNR is at TE ¼ 0. However, due to the T 2 * decay, a very fast CNR decrease is observed for the Ernst angle setting resulting in a decrease of magnitude signal as the echo time increases for high Mn 2þ concentration. However, this decrease in signal intensity does not suggest a reduction of the phase CNR as it can be observed in Figure A1c .
Nevertheless it suggests that the optimum echo time should be reduced for higher Mn 2þ concentrations (as shown by the black line). The optimum echo time decreases from 16 ms to 8 ms (at [Mn 2þ ] ¼ 0.3 mM) due to the T 2 * decay. The plot in Figure A1d shows that, if the optimum echo at pre-Mn 2þ infusion is indeed kept constant, the phase CNR starts to saturate at high concentrations of Mn 2þ (as shown by the dark gray line) although the frequency difference would continue to increase linearly. Consequently, the use of a shorter echo time for post Mn 2þ enrichment would have been preferable as it can be observed at TE ¼ 8 ms where the phase CNR evolution is close to optimum (light gray line). However, when taking into account the range of Mn 2þ concentration obtained in the study (0 to 0.064 mM), at TE ¼ 16 ms no saturation effect is observed as the phase CNR increased linearly with the increased tissue [Mn 2þ ]. Figure A1 .c, the black line shows the optimum echo time for a given Mn 2þ concentration. The dark and light gray lines show the optimum echo time respectively at control and post Mn 2þ infusion for the highest concentration. The plot in (d) shows the evolution of the phase CNR for these three different echo times. Black arrows point to the maximum Mn 2þ concentration obtained in our study (0.064 mM for the Dentate Gyrus) and reported in literature [0.11 mM in Olfactory Bulb (30) ].
